Sheikh Afsana, Kesharwani Prashant, Almalki Waleed H, Almujri Salem Salman, Dai Linxin, Chen Zhe-Sheng, Sahebkar Amirhossein, Gao Fei
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Nanomicro Lett. 2024 May 2;16(1):188. doi: 10.1007/s40820-024-01399-0.
As a new form of regulated cell death, ferroptosis has unraveled the unsolicited theory of intrinsic apoptosis resistance by cancer cells. The molecular mechanism of ferroptosis depends on the induction of oxidative stress through excessive reactive oxygen species accumulation and glutathione depletion to damage the structural integrity of cells. Due to their high loading and structural tunability, nanocarriers can escort the delivery of ferro-therapeutics to the desired site through enhanced permeation or retention effect or by active targeting. This review shed light on the necessity of iron in cancer cell growth and the fascinating features of ferroptosis in regulating the cell cycle and metastasis. Additionally, we discussed the effect of ferroptosis-mediated therapy using nanoplatforms and their chemical basis in overcoming the barriers to cancer therapy.
作为一种新的程序性细胞死亡形式,铁死亡揭示了癌细胞自发产生的内在凋亡抗性理论。铁死亡的分子机制取决于通过过量活性氧积累和谷胱甘肽耗竭诱导氧化应激,从而损害细胞的结构完整性。由于纳米载体具有高负载量和结构可调节性,它们可以通过增强渗透或滞留效应或通过主动靶向将铁治疗剂输送到所需部位。这篇综述阐明了铁在癌细胞生长中的必要性以及铁死亡在调节细胞周期和转移方面的迷人特性。此外,我们讨论了使用纳米平台进行铁死亡介导治疗的效果及其在克服癌症治疗障碍方面的化学基础。